SuppreMol's Acquisition

SuppreMol was acquired by Baxter International on March 04, 2015.

SuppreMol is a privately held biopharmaceutical company developing therapeutics for the treatment of autoimmune and allergic diseases. The company is pioneering the development of soluble Fc-gamma rec…

Articles about SuppreMol's Acquisition: